LOS ANGELES–(BUSINESS WIRE)—- $CDXC #earnings–ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the second quarter of 2022. Second Quarter 2022 and Recent Highlights Total net sales were $16.7 million, with $14.5 million from Tru Niagen®, down 5% and 6% from the prior year period, respectively. Total net sales and Tru…
News Ticker
- [ September 28, 2023 ] STRIKE – RNs and Almost All Health Care Staff to Strike St. Francis Medical Center 10/9 – 10/13 Los Angeles Biotech News
- [ September 28, 2023 ] Medical Laboratory Scientist (Generalist) – Clinical Laboratory – VIR Consultant LLC – Santa Monica, CA Los Angeles Biotech Jobs
- [ September 28, 2023 ] TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for in-hospital BNCT at ASTRO 2023 Annual Meeting Los Angeles Biotech News
- [ September 28, 2023 ] Alfred Mann Foundation Rebrands as huMannity Medtec, Unveiling a Bold, Future-Focused Identity Los Angeles Biotech News
- [ September 28, 2023 ] Medical Laboratory Scientist – VIR Healthway – Santa Monica, CA Los Angeles Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
